Showing results (361-370 of 466) with videos related to

Sort By:
Pageof 47
Journal of Endocrinological Investigation|April 14, 2006
Dose dependency of the serum bio/immuno GH ratio in children during pharmacological secretion testsE A Chaler, P Travaglino, S Pagani, et al.
Nature Communications|September 29, 2015
Multiple-exciton generation in lead selenide nanorod solar cells with external quantum efficiencies exceeding 120Nathaniel J L K Davis, Marcus L Böhm, Maxim Tabachnyk, et al.
Microbial Genomics|September 15, 2018
The first complete genomic structure of Butyrivibrio fibrisolvens and its chromidJavier Rodríguez Hernáez, Maria Esperanza Cerón Cucchi, Silvio Cravero, et al.
International Journal of Antimicrobial Agents|June 15, 2004
Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected miceM S Lo Presti, H W Rivarola, J M Bustamante, et al.
Parasitology|November 10, 2012
Chronic indeterminate phase of Chagas' disease: mitochondrial involvement in infection with two strainsAlejandra Lidia Báez, María Silvina Lo Presti, Ricardo Fretes, et al.
Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)|April 1, 2011
[Importance of host sex in the development of trypanosoma cruzi infection]Lorena R Micucci, Paola C Bazán, Romina Fauro, et al.
Parasitology Research|March 21, 2007
Reinfections and Trypanosoma cruzi strains can determine the prognosis of the chronic chagasic cardiopathy in miceJuan M Bustamante, Mónica Novarese, Héctor W Rivarola, et al.
Medicina|August 9, 2013
[Novel heterozygous mutation in the steroidogenic acute regulatory protein gene in a 46,XY patient with congenital lipoid adrenal hyperplasia]María Sonia Baquedano, Gabriela Guercio, Roxana Marino, et al.
Colloids and Surfaces. B, Biointerfaces|October 13, 2023
Biointerfacial behavior of stallion spermatozoa adhered to hydrogel surfaces: Impact of the hydrogel chemical composition and the culture mediumFrancisca A Ebel, Ana C Liaudat, Damián A Blois, et al.
Vaccine|October 24, 2022
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variantsSebastián Blanco, Lorena Spinsanti, Juan Javier Aguilar, et al.
Pageof 47